Diabetic Foot Treatment in Cuba
An educational guide for families and caregivers exploring diabetic foot treatment in Cuba — the Heberprot-P program, intensive wound care, and complete travel coordination for US patients. Information to support informed decisions, in consultation with your healthcare provider.
Educational Resource — Not Medical Advice
The information on this page is provided for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult with your qualified healthcare provider before making decisions about treatment options.
We do not target, identify, or retarget individuals based on health conditions. This content is intended for families and caregivers seeking information about international treatment options, and is discoverable through organic search.
What Makes Cuba's Program Distinct
Cuba has developed a comprehensive diabetic foot treatment program centered on Heberprot-P — a recombinant human epidermal growth factor (rh-EGF) administered by intra-lesional injection directly into the wound. This therapy, combined with intensive daily wound care and a multidisciplinary team, is not available in the United States.
Heberprot-P Therapy
Cuba's biotechnology innovation — recombinant human epidermal growth factor (rh-EGF) administered directly into diabetic foot wounds. Not available in the US.
Intensive Daily Care
Daily specialist wound care — debridement, dressing changes, offloading, and monitoring — far more intensive than weekly outpatient visits.
Multidisciplinary Team
Endocrinologists, podiatrists, vascular surgeons, infectious disease specialists, and wound care nurses under one roof.
Individualized Programs
4–8 week program cycles tailored to each patient's wound severity, circulation, infection status, and overall health.
Limb Preservation Focus
The program's goal is to heal wounds and preserve the limb. Our team evaluates each patient individually to determine whether the program may be appropriate.
Coordinated Aftercare
A structured handover to your US physician with clinical reports and a monitoring plan for continued care at home.
Your Journey to Cuba
Traveling to Cuba for medical treatment is an authorized travel category for US citizens. Our coordinators handle every step — from e-Visa processing to airport reception in Havana — so you can focus on treatment and recovery.
Medical Records Review
Submit your US medical records, imaging, and wound photos. Our team evaluates your case and determines whether the program may be appropriate — at no cost or obligation.
e-Visa Processing
We guide you through the e-Visa application. Medical treatment is an authorized travel category for US citizens.
Flight Coordination
We help coordinate flights from major US airports to Havana, typically via Miami.
Airport Reception
Our team meets you at José Martí International Airport and provides ground transport to your accommodation.
Accommodation
We coordinate comfortable lodging near the treatment center for patient and family for the duration of the program.
English-Speaking Coordinator
A dedicated coordinator supports you at every step — from arrival through treatment to return home.
The Cuban Diabetic Foot Program
Cuba has developed a comprehensive diabetic foot treatment program centered on Heberprot-P — a recombinant human epidermal growth factor (rh-EGF) administered by intra-lesional injection directly into the wound. This therapy is combined with intensive, multidisciplinary wound care. Our team evaluates each patient individually and determines whether an international wound-care and limb-preservation program may be appropriate. Heberprot-P is not available in the United States.
- Heberprot-P intra-lesional rh-EGF therapy — a Cuban biotechnology innovation
- Intensive daily wound care by specialist teams
- Multidisciplinary team: endocrinologists, podiatrists, vascular surgeons, wound care nurses
- 4–8 week individualized program cycles with continuous monitoring
- Limb preservation focus — our team evaluates each patient individually
- Coordinated aftercare and handover to your US physician
Heberprot-P®
Cuban biotechnology
Recombinant human epidermal growth factor (rh-EGF) developed by Cuba's Center for Genetic Engineering and Biotechnology (CIGB), administered by intra-lesional injection directly into diabetic foot wounds to stimulate healing.
4–8 Week Cycles
Multidisciplinary Team
Diabetic Foot Care by State
Select your state for local diabetes statistics, travel information, and state-specific educational resources for families and caregivers.
Diabetic Foot Care Resources
Explore our full range of educational diabetic foot care resources for US families and caregivers.
From First Inquiry to Safe Return Home
Contact Us
Share your medical information and wound history through our inquiry form.
Free Evaluation
Our wound care team reviews your US records and designs a personalized plan.
Travel Coordination
We assist with e-Visa, flights, and accommodation in Cuba.
Treatment
Receive intensive wound care with Heberprot-P therapy and continuous support.
Aftercare
Coordinated handover to your US physician with a monitoring plan.
Your Questions Answered
Submit Your Medical Records for a Diabetic Foot Evaluation
Our multidisciplinary team evaluates each patient individually and determines whether an international wound-care and limb-preservation program may be appropriate. Share your medical records to receive a personalized assessment — often within 24–48 hours. No obligation, no travel required to get started.